Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biologicals ; 63: 74-80, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31753578

ABSTRACT

The traditional vaccine strains, such as LaSota, do not completely prevent the shedding of NDV. An ideal vaccine which could not only prevent the clinical signs, but significantly reduce the shedding of NDV is urgently needed for the eradication of ND. In this study, an NDV isolate APMV-1/Chicken/China (SC)/PT3/2016 (hereafter referred as PT3) was identified as a class Ⅰ NDV and a lentogenic strain. The antigenic relationship between PT3 and 3 other NDV strains, including vaccine strain LaSota and 2 prevalent genotype Ⅶd and Ⅵb strains were analyzed. The protective efficacy of PT3 and LaSota against challenge with genotype Ⅶd and Ⅵb strains were assessed. The antigenic analysis result showed that 4 strains belong to the single serotype and the PT3 antiserum exhibited the highest HI titer against 3 other NDV strains. The results of protective efficacy showed that both of LaSota and PT3 could provide 100% survivability for infected chickens. However, PT3 performed better in inducing higher humoral responses and reducing virus shedding than the LaSota strain. Lentogenic strains from Class I NDV appear to be promising vaccine candidates for the control of ND, and allows for the easy discrimination of field NDV and vaccine strains.


Subject(s)
Newcastle Disease/prevention & control , Newcastle disease virus/immunology , Poultry Diseases/prevention & control , Viral Vaccines/immunology , Animals , Antibodies, Viral/immunology , Avian Proteins/immunology , Chickens , Newcastle Disease/immunology , Newcastle Disease/pathology , Newcastle disease virus/classification , Poultry Diseases/immunology , Poultry Diseases/pathology
2.
Microbiol Resour Announc ; 8(18)2019 May 02.
Article in English | MEDLINE | ID: mdl-31048383

ABSTRACT

A Newcastle disease virus (NDV) strain, APMV-1/Chicken/China(SC)/PT3/2016, was isolated from asymptomatic chickens at a breeding farm in China. The PT3 strain has a genome length of 15,198 nucleotides and is classified as subgenotype 1b of class I. Pathogenicity tests demonstrated that PT3 is a lentogenic strain.

3.
Vaccine ; 36(28): 4087-4094, 2018 06 27.
Article in English | MEDLINE | ID: mdl-29859801

ABSTRACT

Avian infectious bronchitis (IB) is a highly contagious disease, and hazardous to the poultry industry. Immune failure often occurs due to the emergence of new serotypes or field strains antigenically different from the vaccine strains. To prepare a candidate vaccine against the prevalent avian infectious bronchitis virus (IBV) in China, the GI-19/QX-like field isolate Sczy3 was selected as the progenitor strain and attenuated via passaging in chicken embryo kidney (CEK) cells for 100 times. The 100th generation of CEK-adapted strain, designated SczyC100, was safe to use on one-day old specific pathogen-free (SPF) chicken as determined by pathogenicity and virulence reversion test. The efficacies of SczyC100 and two commonly used commercial vaccines (H120 and 4/91) against prevalent GI-19/QX and GI-7/TWI type virulent strains were evaluated. Sczy3C100 effectively reduced the morbidity, mortality, mean lesion scores (MLSs), and viral load of trachea of chickens challenged by GI-19/QX and GI-7/TWI strains. CEK-adapted SczyC100 is therefore a potential vaccine candidate for the control of IB in China.


Subject(s)
Coronavirus Infections/veterinary , Infectious bronchitis virus/immunology , Poultry Diseases/prevention & control , Viral Vaccines/immunology , Animals , Cell Line , Chickens , China , Coronavirus Infections/immunology , Coronavirus Infections/pathology , Coronavirus Infections/prevention & control , Epithelial Cells/virology , Infectious bronchitis virus/growth & development , Infectious bronchitis virus/pathogenicity , Poultry Diseases/immunology , Serial Passage , Survival Analysis , Trachea/virology , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology , Vaccines, Attenuated/isolation & purification , Viral Load , Viral Vaccines/administration & dosage , Viral Vaccines/isolation & purification , Virulence , Virus Cultivation/methods
4.
Emerg Microbes Infect ; 6(11): e103, 2017 Nov 29.
Article in English | MEDLINE | ID: mdl-29184155

ABSTRACT

Fowl adenovirus (FAdV) has caused significant losses in chicken flocks throughout China in recent years. However, the current understanding of the genetic and pathogenic characteristics of the FAdV epidemic in southwestern China remains poorly understood. In this study, a total of 22 strains were isolated from liver samples of diseased chickens from farms in southwestern China. Phylogenetic analysis based on the hexon loop-1 gene showed that the 22 isolates were clustered into four distinct serotypes: FAdV serotype 4 (FAdV-4) (86.4%, 19/22), FAdV-2 (4.5%, 1/22), FAdV-8a (4.5%, 1/22), and FAdV-8b (4.5%, 1/22). FAdV-4 was the predominant serotype in southwestern China. Pathogenicity testing showed that the FAdV-4 serotype strain CH/GZXF/1602 and FAdV-8a strain CH/CQBS/1504 were pathogenic to chickens, with mortality rates reaching as high as 80% and 20%, respectively. The primary clinical feature observed following infection with strain CH/GZXF/1602 (FAdV-4) was hepatitis-hydropericardium syndrome, and that of strain CH/CQBS/1504 (FAdV-8a) was inclusion body hepatitis. Conversely, the FAdV-2 serotype strain CH/GZXF/1511 and FAdV-8b serotype strain CH/CQBS/1512 was not observed to be pathogenic in chickens. Then, CH/GZXF/1602 (FAdV-4) was selected for the preparation of an inactivated oil-emulsion vaccine. Immune studies on Partridge Shank broilers showed that a single dose immunization at 17 days of age could not only protect against homologous challenge with virulent FAdV-4 but also provided protection against clinical disease following challenge with the heterologous FAdV-8b virulent strain until 70 days of age. The characterization of newly prevalent FAdV strains provides a valuable reference for the development of an efficacious control strategy.


Subject(s)
Adenoviridae Infections/veterinary , Aviadenovirus/classification , Aviadenovirus/genetics , Genetic Variation , Poultry Diseases/virology , Adenoviridae Infections/epidemiology , Adenoviridae Infections/prevention & control , Adenoviridae Infections/virology , Animals , Aviadenovirus/isolation & purification , Aviadenovirus/pathogenicity , Capsid Proteins/genetics , Chickens , China/epidemiology , Genotype , Hepatitis, Viral, Animal/pathology , Hepatitis, Viral, Animal/prevention & control , Hepatitis, Viral, Animal/virology , Liver/virology , Phylogeny , Poultry Diseases/epidemiology , Poultry Diseases/prevention & control , Serogroup , Survival Analysis , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/immunology , Vaccines, Inactivated/isolation & purification , Viral Vaccines/administration & dosage , Viral Vaccines/immunology , Viral Vaccines/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...